QuantuMDx Group Ltd.
Company Snapshot
Founded: 2008
Entity Type: Private
Employees: 121
Region: U.K.
Revenue: $7.0 Millions
Revenue Year: 2023
Headquarter: Newcastle upon Tyne, U.K.
Key Geographics: U.K., Europe, China
Corporate Address: Lugano Bldg, 57 Melbourne St Newcastle upon Tyne, NE1 2JQ U.K. Tel. +44-0-870-803-1234 www.quantumdx.com
Company Overview
Incorporated in 2008, Quantumdx has developed multiplex molecular testing solutions tailored to the point of care.
The point of care solutions (e.g., Q-POC PCR platforms) are engineered to the highest standards, ensuring portability, durability and ease of use. They are designed to be truly portable, powered by batteries, robust, intuitive, safe and user-friendly while delivering exceptional multiplex performance. This design enables healthcare professionals to conduct testing in diverse settings with confidence and efficiency.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Rendering of Goods : This segment includes Multiplex Molecular Diagnostics, PCR Testing Solutions at the Point of Care.
- Technology Transfer Fee : This segment includes fees received from the third party clients for using the company technology.
- R&D Collaboration Income : This segment includes revenue from the partnerships with other companies.
Applications/End User Industries
- Molecular Diagnostics
- Point Of Care
BCC Research Beacon 